Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial.
Geyer T, Rübenthaler J, Alunni-Fabbroni M, Schinner R, Weber S, Mayerle J, Schiffer E, Höckner S, Malfertheiner P, Ricke J. Geyer T, et al. Among authors: mayerle j. Cancers (Basel). 2021 Jun 3;13(11):2787. doi: 10.3390/cancers13112787. Cancers (Basel). 2021. PMID: 34205110 Free PMC article.
[Gastrointestinal innovations].
Malfertheiner P, Mayerle J. Malfertheiner P, et al. Among authors: mayerle j. MMW Fortschr Med. 2018 Nov;160(Suppl 3):58-63. doi: 10.1007/s15006-018-1124-6. MMW Fortschr Med. 2018. PMID: 30421194 Review. German. No abstract available.
Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial.
Alunni-Fabbroni M, Rönsch K, Huber T, Cyran CC, Seidensticker M, Mayerle J, Pech M, Basu B, Verslype C, Benckert J, Malfertheiner P, Ricke J. Alunni-Fabbroni M, et al. Among authors: mayerle j. J Transl Med. 2019 Oct 1;17(1):328. doi: 10.1186/s12967-019-2079-9. J Transl Med. 2019. PMID: 31570105 Free PMC article. Clinical Trial.
Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox.
Kruger S, Schirle K, Haas M, Crispin A, Schirra J, Mayerle J, D'Haese JG, Kunz WG, Ricke J, Ormanns S, Kirchner T, Kobold S, Ilmer M, Gebauer L, Westphalen CB, von Bergwelt-Baildon M, Werner J, Heinemann V, Boeck S. Kruger S, et al. Among authors: mayerle j. J Cancer Res Clin Oncol. 2020 Feb;146(2):391-399. doi: 10.1007/s00432-019-03061-4. Epub 2019 Oct 23. J Cancer Res Clin Oncol. 2020. PMID: 31642961
Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitals.
Steib CJ, Li H, Zhang J, Mayerle J, Ricke J, Gerbes AL, Meyer C, Zipprich A, Trebicka J. Steib CJ, et al. Among authors: mayerle j. Eur J Gastroenterol Hepatol. 2020 Sep;32(9):1179-1185. doi: 10.1097/MEG.0000000000001628. Eur J Gastroenterol Hepatol. 2020. PMID: 31851085
Severe liver failure during SARS-CoV-2 infection.
Weber S, Mayerle J, Irlbeck M, Gerbes AL. Weber S, et al. Among authors: mayerle j. Gut. 2020 Jul;69(7):1365-1367. doi: 10.1136/gutjnl-2020-321350. Epub 2020 Apr 23. Gut. 2020. PMID: 32327526 No abstract available.
390 results